enosix, Inc. Closes $10 Million Financing with MK Capital to Support Real-Time SAP Integration
16.5.2023 16:00:00 EEST | Business Wire | Press release
enosix, Inc., the leading technology provider of real-time, prebuilt SAP data integration solutions, announced the successful completion of its $10 million growth financing led by MK Capital. enosix will use the proceeds to accelerate the development and expansion of its SAP integration platform, while expanding its support of Salesforce, MuleSoft, and ServiceNow clients.
enosix is the proven, SAP data integration approach that is relied upon by leading global manufacturers including recent customer additions, Prevost, a member of Volvo Group, Tremco Inc., and Carl Zeiss AG. enosix empowers SAP ERP customers with the critical last mile of integration in real-time, boosting digital transformation efforts by eliminating error-prone, latent, swivel-chair data entry between systems. enosix uplevels data accuracy, automation and business agility in areas such as, but not limited to, sales quoting, IT asset management, business supply-chain management, B2B eCommerce, and more, allowing for greater utilization of business and SAP skilled resources. These advantages translate to a superior customer experience and greater revenue growth.
“Over the past 30 years we have performed detailed due diligence on hundreds of technology companies,” noted Mark Koulogeorge of MK Capital.“ We have never had a company score higher on product quality and reliability than enosix. The product’s high performance over millions of transactions differentiates enosix from its competitors.”
Jamie Bedard, CEO of SAPinsider observed,“The enterprise landscape for SAP customers continues to become more complex. The accelerated adoption of cloud-based solutions as a result of the global pandemic has only added to this complexity. enosix’s unique approach to real-time, virtualized SAP integration triggers a huge sigh of relief by the SAP industry and offers a potential safety net for tens of thousands of enterprise SAP ERP customers who are not only behind in their S/4HANA migration projects, but those who are trying to keep up with the business demands of digital transformation but don’t have the time, resources, or skilled SAP talent available to support a major traditional integration project.”
Nick Fera, CEO of enosix noted “The increasing demand for pre-built, real-time, bi-directional access to legacy ERP solutions, especially during these difficult economic times, positions enosix for tremendous growth. Companies are tired of paying millions to systems integrators for bespoke integration solutions that offer only synchronous experience and require long-term maintenance. The ability to ‘have a two-way conversation’ with your legacy ERP solutions is no longer a dream, enosix has delivered a platform to handle complex pricing and quoting and is now better positioned to expand.”
About enosix, Inc
enosix is the standard for real-time, prebuilt SAP ERP integration. enosix provides real-time data virtualization, which enables a more agile and compliant customer experience by reducing error-prone data entry and information delays. enosix seamlessly connects SAP ECC and S/4HANA systems to modern front-end systems such as Saleforce, MuleSoft, ServiceNow to support rapid digital transformation. The enosix platform leverages low or no-code Packaged Integration Processes (PIP) so companies can quickly realize value—in weeks instead of months. enosix' use of data virtualization unlocks data, business processes, authorizations, and user permissions from SAP without recreating them from the front-end; delivering the back-end translation in an easy-to-understand, real-time, and bi-directional integration. For more information, visit www.enosix.com
About MK Capital
MK Capital is an early-stage lead investor in the software and cloud services industries. The firm's partners, who average more than 20 years of venture capital experience, actively partner with entrepreneurial management teams to build leading companies that accelerate the digital transformation of the global economy. MK Capital manages over $400 million in capital and is actively seeking new investment opportunities. For more information, visit www.mkcapital.com .
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230516005351/en/
Contact information
Loren Shumate
EMAIL: Loren.Shumate@enosix.com
Follow enosix:
https://enosix.com
https://www.linkedin.com/company/enosix/
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access to BRUKINSA® for the Treatment of Chronic Lymphocytic Leukemia in Low- and Middle-Income Countries18.8.2026 13:00:00 EEST | Press release
BeOne Medicines Ltd. (“BeOne”) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, together with the BeOne Care Foundation, a nonprofit charitable foundation, and The Max Foundation, a leading global health nonprofit organization, today announced the renewal of their partnership through 2028 to expand access to BRUKINSA® (zanubrutinib) for the treatment of chronic lymphocytic leukemia (CLL) in low- and middle-income countries, with the program projected to support approximately 1,000 patients cumulatively. Building on a collaboration launched in 2023, the renewed partnership reflects the organizations’ shared commitment to improving access to innovative cancer treatments in underserved communities. To date, the partnership has enabled access to BRUKINSA for more than 300 patients with CLL across Armenia, Ethiopia, and Nepal, exceeding the program’s original scope by approximately 150 patients and helping establish access to innovative cancer care for patients who previo
Quectel Launches Android 16 Smart Modules for 4G and 5G IoT Devices18.8.2026 11:00:00 EEST | Press release
Quectel Wireless Solutions, a global end-to-end IoT solutions provider, today announces the launch of two new Android 16 smart modules: the SH602FA, a high-performance 4G smart module, and the SE505FE, an entry-level 5G smart module. Designed for industrial and commercial IoT applications, the new modules combine Android 16, integrated wireless connectivity and powerful multimedia capabilities in compact form factors that simplify development and accelerate time-to-market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260818272981/en/ Quectel launches Android 16 smart modules for 4G and 5G IoT devices By bringing Android 16 to both 4G and 5G IoT devices, Quectel enables developers to build smarter connected products with richer user interfaces, enhanced multimedia performance and seamless integration into modern smart building, retail and industrial environments. Android 16 enables connected devices to communicate more inte
Beno Opens Luxury Waterfront Guest Lounge at Marsa Al Arab in Partnership with Jumeirah Group18.8.2026 10:00:00 EEST | Press release
Beno, Dubai's luxury experiences platform, announced the opening of a new premium guest lounge at Marsa Al Arab, developed in partnership with Jumeirah Group, the hospitality arm of Dubai Holding. The lounge adds a permanently staffed guest-services layer to one of Dubai's newest ultra-luxury marine developments. Marsa Al Arab Marina, operated by D-Marin adjacent to Jumeirah Burj Al Arab, offers 82 berths for yachts of up to 61 metres and holds Superyacht Ready and Blue Flag certifications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260818185241/en/ Beno's guest lounge on the marina promenade at Marsa Al Arab, Dubai, with the 115-ft yacht Santorini berthed opposite (Photo: AETOSWire) Beno coordinates yacht charters from the lounge, supported by a nine-vessel fleet berthed at the marina. Among them is Santorini, a 115-ft superyacht featuring five cabins that can accommodate up to 12 overnight guests and up to 80 guests fo
Queue-it Announces Majority Investment from THL Partners18.8.2026 10:00:00 EEST | Press release
Queue-it, a global provider of online traffic orchestration solutions, today announced that it has entered a definitive agreement for a majority investment from THL Partners (“THL”), a premier investment firm investing in middle-market growth companies. Together, THL and Queue-it will focus on accelerating product innovation and expanding the company’s global reach. Founded and headquartered in Denmark, Queue-it helps enterprises and public organizations manage online traffic surges, protect digital infrastructure, mitigate bots and abuse, and deliver fair, reliable access to critical online services. Its platform is trusted by organizations around the world and operates across ticketing, retail, government, financial services, and other mission-critical industries. THL’s partnership with Queue-it builds on the firm’s longstanding investment focus on IT Operations & Data, which includes software companies that help organizations operate, secure, and optimize increasingly complex digita
Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™17.8.2026 22:44:00 EEST | Press release
Nanochon, a medical device company developing Chondrograft™, a novel patented implant for the treatment of articular cartilage defects of the knee, today announced that it has received regulatory approval from Panamá’s Ministry of Health to initiate its First-in-Human (FIH) clinical study in Panamá. The study will evaluate the safety and performance of Chondrograft™ in patients with focal chondral defects of the knee and represents a major milestone in the company’s clinical and regulatory development strategy. The trial will be conducted at The Panama Clinic in Panamá City under the leadership of Drs. Juan Osorio and Emilio Tufiño, experienced sports medicine surgeons, with Dr. Osorio serving as Principal Investigator for the study. Dr. Osorio stated, “I am pleased to be the Principal Investigator for this important study, and we look forward to contributing the data that will support a larger clinical study and subsequent market entry.” Nanochon selected Panamá for its growing reputa
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
